Over the past year, BRVE insiders bought $122.61 million of stock (6.81Mn shares) on the open market and sold none.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Growth Opportunities Fund Iii Cooperatief U.A. Forbion | TenPercentOwner | 11,640,546 | 10,185,478 | 21,826,024 | 48.5% | 07 Aug, 2026 |
| 2 | Bio Fund Iv, L.P. Ah | TenPercentOwner | 0 | 10,232,420 | 10,232,420 | 22.7% | 11 Aug, 2026 |
| 3 | Hengrui Pharmaceuticals Co., Ltd. Jiangsu | TenPercentOwner | 7,420,091 | 0 | 7,420,091 | 16.5% | 10 Aug, 2026 |
| 4 | Travis Murdoch | Ceo And President | 2,940,670 | 0 | 2,940,670 | 6.5% | 07 Aug, 2026 |
| 5 | Christopher Viehbacher | Director | 609,519 | 0 | 609,519 | 1.4% | 07 Aug, 2026 |
| 6 | David I Malek | Director | 533,845 | 0 | 533,845 | 1.2% | 07 Aug, 2026 |
| 7 | James Paul Rickey | Chief Financial Officer | 520,927 | 0 | 520,927 | 1.2% | 07 Aug, 2026 |
| 8 | Michele A. Anderson | Chief Development Officer | 332,161 | 0 | 332,161 | 0.7% | 07 Aug, 2026 |
| 9 | Erez Chimovits | Director, TenPercentOwner | 0 | 273,333 | 273,333 | 0.6% | 11 Aug, 2026 |
| 10 | Advisors Llc Orbimed | Director, TenPercentOwner | 0 | 273,333 | 273,333 | 0.6% | 11 Aug, 2026 |
| 11 | David Charles Lubner | Director | 55,555 | 0 | 55,555 | 0.1% | 07 Aug, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 07 Aug, 2026 | Erez Chimovits | Director, TenPercentOwner | Acquired C | 9,132,420 | — | — | 10,235,159 | Indirect |
| 07 Aug, 2026 | Bio Fund Iv, L.P. Ah | TenPercentOwner | Acquired C | 9,132,420 | — | — | 9,132,420 | Indirect |
| 07 Aug, 2026 | Advisors Llc Orbimed | Director, TenPercentOwner | Acquired C | 9,132,420 | — | — | 10,235,159 | Indirect |
| 07 Aug, 2026 | Erez Chimovits | Director, TenPercentOwner | Acquired P | 1,666,667 | $18.00 | $30.00Mn | 11,901,826 | Indirect |
| 07 Aug, 2026 | Advisors Llc Orbimed | Director, TenPercentOwner | Acquired P | 1,666,667 | $18.00 | $30.00Mn | 11,901,826 | Indirect |
| 07 Aug, 2026 | Bio Fund Iv, L.P. Ah | TenPercentOwner | Acquired P | 1,100,000 | $18.00 | $19.80Mn | 10,232,420 | Indirect |
| 07 Aug, 2026 | Bio Fund Iv, L.P. Ah | TenPercentOwner | Disposed C | 40,000,000 | $0.00 | $0 | 0 | Indirect |
| 07 Aug, 2026 | Advisors Llc Orbimed | Director, TenPercentOwner | Acquired P | 273,333 | $18.00 | $4.92Mn | 273,333 | Indirect |
| 07 Aug, 2026 | Erez Chimovits | Director, TenPercentOwner | Acquired P | 273,333 | $18.00 | $4.92Mn | 273,333 | Indirect |
| 07 Aug, 2026 | Erez Chimovits | Director, TenPercentOwner | Disposed C | 40,000,000 | $0.00 | $0 | 0 | Indirect |
| 07 Aug, 2026 | Advisors Llc Orbimed | Director, TenPercentOwner | Disposed C | 40,000,000 | $0.00 | $0 | 0 | Indirect |
| 07 Aug, 2026 | Hengrui Pharmaceuticals Co., Ltd. Jiangsu | TenPercentOwner | Acquired C | 7,420,091 | — | — | 7,420,091 | Direct |
| 07 Aug, 2026 | Hengrui Pharmaceuticals Co., Ltd. Jiangsu | TenPercentOwner | Disposed C | 32,500,000 | $0.00 | $0 | 0 | Direct |
| 07 Aug, 2026 | Christopher Viehbacher | Director | Acquired P | 83,333 | $18.00 | $1.50Mn | 609,519 | Direct |
| 07 Aug, 2026 | Growth Opportunities Fund Iii Cooperatief U.A. Forbion | TenPercentOwner | Acquired C | 9,132,420 | $0.00 | $0 | 9,720,546 | Direct |
| 07 Aug, 2026 | David Charles Lubner | Director | Acquired P | 55,555 | $18.00 | $999.99K | 55,555 | Direct |
| 05 Aug, 2026 | Jasper Bos | Director | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 05 Aug, 2026 | Tim Lohoff | Director | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 05 Aug, 2026 | Erez Chimovits | Director, TenPercentOwner | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 07 Aug, 2026 | Michele A. Anderson | Chief Development Officer | Acquired P | 1,111 | $18.00 | $20.00K | 332,161 | Direct |